Pfizer ( PFE 1.46%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such ...

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. Image source: . Pfizer has a ...

Bispecific anti-PD1/VEGF remains one of the hottest topics in the oncology field. Click here for a detailed analysis.

Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new ...

Morgan Stanley maintained an 'overweight' rating on ITC Ltd. with a target price of Rs 500, citing strong topline growth ...

When investors buy a ... dividend stocks, this list is an excellent place to start. All seven of the stocks below have a consistent history of distributing monthly income. It’s a good bet ...